# Nimodipine

## Nimotop inj 10mg/ 50mL

##### 

| 藥品代碼   | INIM                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |
|:-----------|:-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| 適應症     | Prophylaxis & treatment of ischaemic neurological deficits caused by cerebral vasospasms following subarachnoid haemorrhage.                                                                                                                                                                                                                                                                                                                                                                                                               |
| 用法用量   | Subarachnoid hemorrhage， From ruptured intracranial berry aneurysms prophylaxis: initial， 0.5 mg/hr (hemadynamics unstable patient) to 1mg/hr (15mcg/kg/hr) for 2hr， then slowly titrate to 2mg/hr. (usually start drug within 4 days， then keep therapy for10-14days. if Craniotomy: continue IVD for at least 5 days after craniotomy. Then switch to ORALLY 60mg q4h for 7 days. treatment: initial， 1mg/hr (15mcg/kg/hr) for 2hr， then slowly titrate to 2mg/hr for 5-14days. after that， switch to ORALLY 60mg q4h for 7 days. |
| 肝功能異常 | 需調整劑量                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |
| 腎功能異常 | 無需調整劑量                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
| 禁忌       | Must not be administered to patients with severely impaired liver function                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |
| 副作用     | Hypotension， GI disturbances.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             |
| 孕期建議   | No (limited) human data – animal data suggest risk                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         |
| 哺乳期建議 | No (Limited) Human Data - Probably Compatible 無(很少)資料 - 可使用                                                                                                                                                                                                                                                                                                                                                                                                                                                                        |

## Nimotop F.C 30mg

##### 

| 藥品代碼   | ONIM                                                                                                                                                                                                  |
|:-----------|:------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| 適應症     | Prophylaxis & treatment of ischaemic neurological deficits caused by cerebral vasospasms following subarachnoid haemorrhage.                                                                          |
| 用法用量   | Subarachnoid hemorrhage， From ruptured intracranial berry aneurysms: treatment or prophylaxis: 60mg Q4H for 7 days (1 hour before or 2 hours after meals)， after IV infusion Nimotop for 5-14 days. |
| 肝功能異常 | 需調整劑量                                                                                                                                                                                            |
| 腎功能異常 | 無需調整劑量                                                                                                                                                                                          |
| 禁忌       | Patients with severely impaired liver function (eg， cirrhosis of the liver). In view of its indication area， Nimotop tablet is not used during pregnancy or lactation.                              |
| 副作用     | Hypotension， GI disturbances.                                                                                                                                                                        |
| 孕期建議   | No (limited) human data – animal data suggest risk                                                                                                                                                    |
| 哺乳期建議 | No (Limited) Human Data - Probably Compatible 無(很少)資料 - 可使用                                                                                                                                   |

